logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 [see all tables in this series...]

Part (iv) Percentage distribution of all outpatient clients by primary drug for age at first use

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates18.636.555.455.955.352.849.847.67347919741
Cocaine11.821.227.230.130.632.132.3264059810367
Stimulants7.49.94.93.82.82.62.41.1129293389
Hypnotics and sedatives1.71.834.26.27.51017.450301840
Hallucinogens1.72.21.10.60.30.40.20.32768661
Volatile substances0.70.20.10.1000.10.335967
Cannabis 57.127.584.94.34.23.26.24125312256
Other substances 10.70.40.50.50.421.211371633
Total24775819513851416907815641081955118717755349954

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LU, MT, NL, AT, SK, FI, SE. 

 Last data available from Spain refer to 2005. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-107 on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008